Charles Schwab’s Rockwell Medical RMTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,618
| Closed | -$207K | – | 3522 |
|
|
2021
Q1 | $207K | Buy |
1,618
+152
| +10% | +$22.5K | ﹤0.01% | 3316 |
|
|
2020
Q4 | $163K | Hold |
1,466
| – | – | ﹤0.01% | 3279 |
|
|
2020
Q3 | $173K | Hold |
1,466
| – | – | ﹤0.01% | 3199 |
|
|
2020
Q2 | $315K | Buy |
1,466
+86
| +6% | +$20.3K | ﹤0.01% | 3025 |
|
|
2020
Q1 | $312K | Buy |
1,380
+81
| +6% | +$23.1K | ﹤0.01% | 2881 |
|
|
2019
Q4 | $349K | Hold |
1,299
| – | – | ﹤0.01% | 2938 |
|
|
2019
Q3 | $395K | Buy |
1,299
+125
| +11% | +$38.4K | ﹤0.01% | 2891 |
|
|
2019
Q2 | $389K | Buy |
1,174
+204
| +21% | +$104K | ﹤0.01% | 2930 |
|
|
2019
Q1 | $607K | Hold |
970
| – | – | ﹤0.01% | 2695 |
|
|
2018
Q4 | $242K | Buy |
970
+75
| +8% | +$29.8K | ﹤0.01% | 2993 |
|
|
2018
Q3 | $416K | Sell |
895
-95
| -10% | -$46K | ﹤0.01% | 2902 |
|
|
2018
Q2 | $538K | Buy |
990
+118
| +14% | +$70.8K | ﹤0.01% | 2786 |
|
|
2018
Q1 | $500K | Buy |
872
+157
| +22% | +$99.1K | ﹤0.01% | 2730 |
|
|
2017
Q4 | $459K | Hold |
715
| – | – | ﹤0.01% | 2741 |
|
|
2017
Q3 | $674K | Hold |
715
| – | – | ﹤0.01% | 2632 |
|
|
2017
Q2 | $625K | Hold |
715
| – | – | ﹤0.01% | 2623 |
|
|
2017
Q1 | $493K | Hold |
715
| – | – | ﹤0.01% | 2648 |
|
|
2016
Q4 | $516K | Hold |
715
| – | – | ﹤0.01% | 2638 |
|
|
2016
Q3 | $528K | Hold |
715
| – | – | ﹤0.01% | 2597 |
|
|
2016
Q2 | $596K | Hold |
715
| – | – | ﹤0.01% | 2531 |
|
|
2016
Q1 | $592K | Hold |
715
| – | – | ﹤0.01% | 2519 |
|
|
2015
Q4 | $806K | Buy |
715
+93
| +15% | +$108K | ﹤0.01% | 2462 |
|
|
2015
Q3 | $528K | Hold |
622
| – | – | ﹤0.01% | 2596 |
|
|
2015
Q2 | $1.1M | Hold |
622
| – | – | ﹤0.01% | 2377 |
|
|
2015
Q1 | $748K | Buy |
622
+110
| +21% | +$129K | ﹤0.01% | 2485 |
|
|
2014
Q4 | $579K | Hold |
512
| – | – | ﹤0.01% | 2562 |
|
|
2014
Q3 | $515K | Hold |
512
| – | – | ﹤0.01% | 2578 |
|
|
2014
Q2 | $676K | Hold |
512
| – | – | ﹤0.01% | 2509 |
|
|
2014
Q1 | $713K | Hold |
512
| – | – | ﹤0.01% | 2444 |
|
|
2013
Q4 | $588K | Hold |
512
| – | – | ﹤0.01% | 2530 |
|
|
2013
Q3 | $645K | Hold |
512
| – | – | ﹤0.01% | 2445 |
|
|
2013
Q2 | $197K | Buy |
+512
| New | +$217K | ﹤0.01% | 2905 |
|
Other funds holding RMTI
PCM
TEE
VCA
Charles Schwab's RMTI Position: Q2 2021 in Review
Charles Schwab sold out of Rockwell Medical (RMTI) in Q2 2021, closing a stake of 1,618 shares — an estimated $207K sold.
Charles Schwab first reported a position in RMTI in Q2 2013 and held it in 32 quarters. The position peaked at $1.1M in Q2 2015. 78 funds tracked by Wall St. Rank hold RMTI as of Q2 2021.
- Charles Schwab reported no remaining Rockwell Medical position as of Q2 2021 after selling out during the quarter.
- Charles Schwab sold 1,618 Rockwell Medical shares in Q2 2021, an estimated $207K.
- Charles Schwab first reported a position in Rockwell Medical in Q2 2013 and held it in 32 quarters.
- Charles Schwab's Rockwell Medical position peaked at $1.1M in Q2 2015.
- 78 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2021.
Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.